Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
- A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune DiseasesWithdrawn
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Multiple Sclerosis (MS) · Neuromyelitis Optica Spectrum Disease (NMOSD) · Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD) · Myasthenia Gravis
China
- Peer Support Impact on Therapeutic Adherence in Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Nantes University Hospital
Multiple Sclerosis, Relapsing-remitting
France
Sponsor: University of Patras
Multiple Sclerosis · Gait Disorders, Neurologic · Postural Balance · Motion Analysis
Greece
Sponsor: University Hospital, Bordeaux
Renal Angiomyolipomas · Tuberous Sclerosis
France
Sponsor: National Tuberous Sclerosis Association
Tuberous Sclerosis · Lymphangioleiomyomatosis
United States, Canada
- Comprehensive Rehabilitation Programme in People With Multiple Sclerosis: The RECONNECT-MS StudyNot Yet Recruiting
Sponsor: Charles University, Czech Republic
Multiple Sclerosis
Czechia
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
Sponsor: University of Michigan
Multiple Sclerosis · Spinal Cord Injury
United States
Sponsor: University Hospital, Montpellier
Relapsing-Remitting Multiple Sclerosis (RRMS) · Anti-CD20 Therapy
France
- Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Austria, Brazil, Bulgaria, Canada +12 more
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Primary Progressive
United States, Argentina, Australia, Austria, Brazil +23 more
Sponsor: Pamukkale University
Multiple Sclerosis
Turkey (Türkiye)
- Gait Adaptation StudyRecruiting
Sponsor: Rutgers, The State University of New Jersey
Aging
United States
Sponsor: Centre Hospitalier Universitaire de Nīmes
Multiple Sclerosis (MS) - Relapsing-remitting
France
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Neuromyelitis Optica Spectrum Disorders (NMOSD) · Multiple Sclerosis · Autoimmune Encephalitis · Myasthenia Gravis
China
- Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple SclerosisRecruiting
Sponsor: Georgia State University
Multiple Sclerosis (Relapsing Remitting)
United States
Sponsor: St. Jude Children's Research Hospital
Acute Leukemia · Adenomatous Polyposis · Adrenocortical Carcinoma · AML
United States
- Effects of Ocrevus in Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: Georgia State University
Relapsing Multiple Sclerosis
United States
- Diagnostic Value of eVOGRecruiting
Sponsor: Centre Hospitalier Universitaire de Nice
Multiple Sclerosis · Radiologically Isolated Syndrome · White Matter Lesions
France
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Germany
Sponsor: Rennes University Hospital
Multiple Sclerosis
France
Sponsor: Rennes University Hospital
Multiple Sclerosis
France
Sponsor: ModernaTX, Inc.
Multiple Sclerosis
United States, Australia, United Kingdom
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Switzerland
- PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple SclerosisNot Yet Recruiting
Sponsor: Nantes University Hospital
Relapsing - Remitting Multiple Sclerosis
France